Shaw T, Smillie R H, Miller A E, MacPhee D G
Department of Microbiology, La Trobe University, Bundoora, Australia.
Mutat Res. 1988 Jul-Aug;200(1-2):117-31. doi: 10.1016/0027-5107(88)90075-9.
Blood platelets are the smallest cellular elements in mammalian blood. Because of their small size, platelets have an unusually large surface area: volume ratio and are exquisitely sensitive to a multitude of physiological and environmental stimuli. Platelets lack nuclei, but most possess functional mitochondria and remain capable of both anaerobic and aerobic energy metabolism, for which they utilise a variety of substrates including many which are cytotoxic and genotoxic for other (nucleated) cells. Nucleic acid precursors are amongst the potentially genotoxic compounds for which platelets have an apparently insatiable appetite. In particular platelets actively scavenge adenine and adenosine, which they convert to nucleotides and use in energy metabolism, but they also rapidly phosphorylase thymidine and liberate thymine into the extracellular medium. In addition, platelets contain non-metabolisable membrane-bound pools of adenine nucleotides which they secrete in response to strong agonists. Taken together, these observations suggest that blood platelets play an important role in nucleic acid precursor metabolism. In the previous paper we have shown that most thymidine phosphorylase activity present in normal human blood resides in the cytoplasm of platelets. Here we demonstrate that this enzyme activity can be modulated in a dose-dependent fashion, not only by substances recognised as platelet agonists and antagonists, but also by some compounds which are considered to be toxic, mutagenic and/or carcinogenic. The data which we present provide additional support for our previous suggestion that platelets regulate thymidine homeostasis and further imply that this is the normal, physiological, platelet function. Preliminary results suggest that assays of blood platelet thymidine metabolism may provide data with a wide variety of applications.
血小板是哺乳动物血液中最小的细胞成分。由于其体积小,血小板具有异常大的表面积与体积比,并且对多种生理和环境刺激极为敏感。血小板没有细胞核,但大多数拥有功能性线粒体,并且仍然能够进行无氧和有氧能量代谢,为此它们利用多种底物,包括许多对其他(有核)细胞具有细胞毒性和基因毒性的底物。核酸前体是血小板明显贪得无厌的潜在基因毒性化合物之一。特别是血小板会积极清除腺嘌呤和腺苷,将它们转化为核苷酸并用于能量代谢,但它们也会迅速磷酸化胸苷并将胸腺嘧啶释放到细胞外介质中。此外,血小板含有不可代谢的膜结合腺嘌呤核苷酸池,它们会在强烈激动剂的作用下分泌这些核苷酸。综上所述,这些观察结果表明血小板在核酸前体代谢中起重要作用。在之前的论文中,我们已经表明正常人血液中存在的大多数胸苷磷酸化酶活性存在于血小板的细胞质中。在这里,我们证明这种酶活性不仅可以被公认为血小板激动剂和拮抗剂的物质,而且可以被一些被认为有毒、诱变和/或致癌的化合物以剂量依赖的方式调节。我们提供的数据为我们之前关于血小板调节胸苷稳态的建议提供了额外的支持,并进一步暗示这是正常的生理血小板功能。初步结果表明,血小板胸苷代谢检测可能会提供具有广泛应用的数据。